Antibiotic therapy in reconstructive surgery of deep sternal wound infections.

P Unbehaun, L Prantl, S Langer, N Spindler
{"title":"Antibiotic therapy in reconstructive surgery of deep sternal wound infections.","authors":"P Unbehaun, L Prantl, S Langer, N Spindler","doi":"10.3233/CH-238121","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The choice of antibiotics and length of administration in the treatment of deep sternal wound infections (DSWI) is unclear. The reason for this is the lack of studies and local differences in resistance. An increase in resistance can be observed in gram-positive cocci, which are the most frequently detected in deep sternal infections. The duration of administration is often 2- 6 weeks or longer, although the benefit of prolonged antibiotic administration has not been confirmed by studies. We evaluated the antibiotic treatment during surgical treatment, consisting of surgical wound debridement and plastic chest reconstruction.</p><p><strong>Methods: </strong>Retrospective analysis of patients (n = 260) who underwent reconstructive surgery in the Department of Plastic Surgery at Leipzig University Hospital from 01.05.2012 - 31.12.2020. The duration of intake, results of microbiological swabs and resistance were investigated.</p><p><strong>Results: </strong>At the time of discharge, closed wound conditions were noted in 177 of 260 cases (68.1%). The largest proportion of patients (n = 238) was treated with a latissimus dorsi flap (91.5%).Antibiotic treatment was conducted in 206 of 260 cases (79.2%). The mean duration of antibiotic administration was 21.4 days (±17.6). Prolonged treatment over 14 days did not alter outcome (p = 0.226), in contrast, the number of multidrug resistances (p < 0.001). There was no prove of resistance against linezolid which is effective against the most common found infectious agents Staphylococcus epidermidis (n = 93; 24.0 %) & Staphylococcus aureus (n = 47; 12.1 %).</p><p><strong>Conclusion: </strong>There is no evidence of benefit from antibiotic therapy over 14 days, whereas multidrug resistance increases with prolonged antibiotic use. In the absence of infectious agents or clinical signs of inflammation, surgical treatment without additional antibiotic treatment is effective.Linezolid is a suitable antibiotic in the treatment of gram-positive infections which are the most frequent in DSWI.</p>","PeriodicalId":93943,"journal":{"name":"Clinical hemorheology and microcirculation","volume":" ","pages":"183-194"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical hemorheology and microcirculation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/CH-238121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The choice of antibiotics and length of administration in the treatment of deep sternal wound infections (DSWI) is unclear. The reason for this is the lack of studies and local differences in resistance. An increase in resistance can be observed in gram-positive cocci, which are the most frequently detected in deep sternal infections. The duration of administration is often 2- 6 weeks or longer, although the benefit of prolonged antibiotic administration has not been confirmed by studies. We evaluated the antibiotic treatment during surgical treatment, consisting of surgical wound debridement and plastic chest reconstruction.

Methods: Retrospective analysis of patients (n = 260) who underwent reconstructive surgery in the Department of Plastic Surgery at Leipzig University Hospital from 01.05.2012 - 31.12.2020. The duration of intake, results of microbiological swabs and resistance were investigated.

Results: At the time of discharge, closed wound conditions were noted in 177 of 260 cases (68.1%). The largest proportion of patients (n = 238) was treated with a latissimus dorsi flap (91.5%).Antibiotic treatment was conducted in 206 of 260 cases (79.2%). The mean duration of antibiotic administration was 21.4 days (±17.6). Prolonged treatment over 14 days did not alter outcome (p = 0.226), in contrast, the number of multidrug resistances (p < 0.001). There was no prove of resistance against linezolid which is effective against the most common found infectious agents Staphylococcus epidermidis (n = 93; 24.0 %) & Staphylococcus aureus (n = 47; 12.1 %).

Conclusion: There is no evidence of benefit from antibiotic therapy over 14 days, whereas multidrug resistance increases with prolonged antibiotic use. In the absence of infectious agents or clinical signs of inflammation, surgical treatment without additional antibiotic treatment is effective.Linezolid is a suitable antibiotic in the treatment of gram-positive infections which are the most frequent in DSWI.

胸骨深创面感染重建手术中的抗生素治疗。
在治疗深胸骨伤口感染(DSWI)时,抗生素的选择和给药时间尚不清楚。其原因是缺乏研究和当地的耐药性差异。在革兰氏阳性球菌中可观察到耐药性增加,这种球菌在深胸骨感染中最常被发现。给药的持续时间通常为2- 6周或更长,尽管延长抗生素给药的益处尚未得到研究的证实。我们评估了手术治疗期间的抗生素治疗,包括手术伤口清创和胸部整形重建。方法:回顾性分析2012年5月1日至2020年12月31日在莱比锡大学医院整形外科接受重建手术的患者260例。并对摄食时间、微生物拭子结果及耐药性进行了调查。结果:出院时,260例患者中有177例创面闭合,占68.1%。采用背阔肌皮瓣治疗的患者比例最大(238例),占91.5%。260例中有206例(79.2%)接受抗生素治疗。平均给药时间为21.4天(±17.6天)。延长治疗超过14天没有改变结果(p = 0.226),相反,多药耐药的数量(p < 0.001)。没有证据表明对利奈唑胺有耐药性,利奈唑胺对最常见的传染性病原体表皮葡萄球菌有效(n = 93;24.0%)和金黄色葡萄球菌(n = 47;12.1%)。结论:没有证据表明抗生素治疗超过14天有益,而多药耐药随着抗生素使用时间的延长而增加。在没有感染因子或炎症临床体征的情况下,手术治疗无需额外的抗生素治疗是有效的。利奈唑胺是治疗革兰氏阳性感染的合适抗生素,而革兰氏阳性感染在社会福利和社会发展倡议中最为常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信